This finding is in agreement with what was observed by previous studies, as the results showed a low count of CD3+, CD4+, and CD8+ T cells in COVID-19 patients, particularly in moderate and severe cases (20, 34, 35). This evidence concerns the gene CD8A and COVID-19.